Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial

CONCLUSION: Patients with shorter TL presented a higher risk of developing T2DM. This association could be mitigated with a specific dietary pattern, in our case a Mediterranean diet, to prevent T2DM in patients with coronary heart disease.TRIAL REGISTRATION: Clinicaltrials.gov number NCT00924937.PMID:38493287 | PMC:PMC10944592 | DOI:10.1186/s12933-024-02175-5

Source: Atherosclerosis - March 17, 2024 Category: Cardiology Authors: Ana Ojeda-Rodriguez Oriol A Rangel-Zu ñiga Antonio P Arenas-de Larriva Francisco M Gutierrez-Mariscal Jose D Torres-Pe ña Juan L Romero-Cabrera Alicia Podadera-Herreros Helena Garc ía-Fernandez Esther Porras-P érez Raul M Luque Stefanos N Kales Pablo Source Type: research